//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
Amazing presentation by @rociovacikdiaz.bsky.social at European Congress on Thrombosis and Haemostasis (ECTH) 2025: impact of LVAD implantation on circulating proteome with a focus on the early dynamic changes. Work from Team 2 led by Professor @sophiesusen.bsky.social , UMR1011
Congratulations to @melaniedaniel.bsky.social MD at CHU de Lille and at UMR1011 team 2, led by Pr @sophiesusen.bsky.social) for her great presentation at the European Congress on Thrombosis and Haemostasis : “Unbiased assessment of VWD burden and healthcare consumption using pseudonymized big data.”
Congrats to @mickaelrosa.bsky.social and Pr Antoine Rauch on winning the Bernd R. Binder publication prize at ECTH for their 2023 paper : role of ECMO-associated shear forces on GPIba shedding resulting in platelet clearance and thrombocytopenia. Team 2 Pr @sophiesusen.bsky.social, UMR1011
Wonderful presentation by @mickaelrosa.bsky.social in the Science Fast and Furious session at ECTH2025 in Prague : effect of emicizumab focusing on monocytes/macrophages using single cell and transcriptomic data. Work from team 2 led by Professor @sophiesusen.bsky.social, UMR1011.
We are honored to welcome @riittalassila.bsky.social to Paris for the French Society of Hematology's talk on Red Blood Cells in Hemostasis. Thank you! #sfh #sfth #hemsky #hemesky
Plenary session at the SFH with Prof. Marie-Christine Alessi invited for a talk on phenotype/genotype in platelet disorders with Hana Raslova as moderator. #hemesky #hemsky #sfh
Maladies cardiovasculaires : un médicament à l’essai pour prévenir de la sténose aortique 👇 Lire le communiqué : presse.inserm.fr/maladies-car... @chulille.bsky.social @univlille.bsky.social
🔬 Sténose aortique : un traitement médicamenteux ? L’équipe des Prs Susen et Van Belle a identifié une nouvelle piste thérapeutique : l’acide rétinoïque, qui pourrait ralentir la calcification de la valve aortique. Ce médicament offrirait une alternative au remplacement valvulaire 🫀.
@sfthemostase.bsky.social
Very proud to be invited to the RFHT journal for the Year of hemostasis. Was an amazing experience. #rfht
8mo
8mo
8mo
8mo
Apr 4, 2025
Apr 2, 2025
Feb 26, 2025
Feb 14, 2025
Mar 3, 2025
Feb 4, 2025
Société Française de Thrombose et d'Hémostase
Société Française de Thrombose et d'Hémostase
CHU de Lille
Sophie Susen
Inserm
Alex K
A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with full-dose blood thinners. #NEJM www.nejm.org/doi/full/10....
Feb 14, 2025
Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is associated with antibodies that target platelet factor 4 (PF4) and are heparin-independent. VITT antibodies are implicated in acute,...
www.nejm.org
VITT-like Monoclonal Gammopathy of Thrombotic Significance | NEJM
Science News